Phase 3 Readout~month

Phase 3 Topline: A Multicenter, Randomized, Double Blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Pa

Indication
Gorlin Syndrome

Other upcoming events for SLGL

Patent ExpiryPatent/Exclusivity Expiry: VITEKTA
Patent ExpiryPatent/Exclusivity Expiry: GENVOYA
Patent ExpiryPatent/Exclusivity Expiry: STRIBILD
Patent ExpiryPatent/Exclusivity Expiry: PAXLOVID (COPACKAGED)

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Multicenter, Randomized, Double Blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Pa — SLGL Phase 3 Readout | BioSniper